Skip to main content
Equibles

IOLCP · IOL Chemicals and Pharmaceuticals Limited · Financials

Use IOLCP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IOLCP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
201.63 INR -3.45 (-1.68%) At close · Nov 13
Rebalance outlook locked
Market Cap
59.18B INR
Shares
293.53M
Volume · Nov 13 2.06M Avg daily vol (3M) 3.97M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
23.19B +11.5%
FY2026 Revenue FY2022–FY2026
Net Income
1.38B +36.2%
FY2026 Net Income FY2022–FY2026
Operating Cash Flow
2.14B +20%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022
INR 27.51B 23.19B 20.79B 21.33B 22.17B 21.84B
INR 840.1M 802.3M 719.9M 629.1M 461.6M 432.6M
INR 159.2M 145.5M 147.6M 161M 164.7M 82.9M
INR 2.72B 1.84B 1.38B 1.82B 1.89B 2.25B
INR 691.3M 467.2M 368.9M 472.2M 495.1M 571.8M
INR 2.03B 1.38B 1.01B 1.34B 1.39B 1.68B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.41B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.